カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界の豚用弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global Live Attenuated Vaccine for Pig Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23SM7912）・商品コード：GIR23SM7912
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年9月
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の豚用弱毒生ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の豚用弱毒生ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 豚用弱毒生ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

豚用弱毒生ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・細菌ワクチン、ウイルスワクチン

用途別セグメント
・子豚、成豚

主要な市場プレーヤー
・Merck、Pfizer、GlaxoSmithKline、Astellas Pharma、Johnson & Johnson、CSL、KM Biologics、MSD Animal Health

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、豚用弱毒生ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な豚用弱毒生ワクチンメーカーの企業概要、2019年～2022年までの豚用弱毒生ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な豚用弱毒生ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別豚用弱毒生ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの豚用弱毒生ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での豚用弱毒生ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および豚用弱毒生ワクチンの産業チェーンを掲載しています。
・第14、15章では、豚用弱毒生ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 豚用弱毒生ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：細菌ワクチン、ウイルスワクチン
– 用途別分析（2018年vs2022年vs2029年）：子豚、成豚
– 世界の豚用弱毒生ワクチン市場規模・予測
– 世界の豚用弱毒生ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Pfizer、GlaxoSmithKline、Astellas Pharma、Johnson & Johnson、CSL、KM Biologics、MSD Animal Health
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：細菌ワクチン、ウイルスワクチン
・用途別分析2018年-2029年：子豚、成豚
・豚用弱毒生ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・豚用弱毒生ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・豚用弱毒生ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・豚用弱毒生ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・豚用弱毒生ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Live Attenuated Vaccine for Pig
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Live Attenuated Vaccine for Pig Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Bacterial Vaccines
1.3.3 Viral Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Live Attenuated Vaccine for Pig Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglet
1.4.3 Adult Pig
1.5 Global Live Attenuated Vaccine for Pig Market Size & Forecast
1.5.1 Global Live Attenuated Vaccine for Pig Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Live Attenuated Vaccine for Pig Sales Quantity (2018-2029)
1.5.3 Global Live Attenuated Vaccine for Pig Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Live Attenuated Vaccine for Pig Product and Services
2.1.4 Merck Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Live Attenuated Vaccine for Pig Product and Services
2.2.4 Pfizer Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Live Attenuated Vaccine for Pig Product and Services
2.3.4 GlaxoSmithKline Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Recent Developments/Updates
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business
2.4.3 Astellas Pharma Live Attenuated Vaccine for Pig Product and Services
2.4.4 Astellas Pharma Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Astellas Pharma Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Live Attenuated Vaccine for Pig Product and Services
2.5.4 Johnson & Johnson Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Live Attenuated Vaccine for Pig Product and Services
2.6.4 CSL Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CSL Recent Developments/Updates
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Live Attenuated Vaccine for Pig Product and Services
2.7.4 KM Biologics Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 KM Biologics Recent Developments/Updates
2.8 MSD Animal Health
2.8.1 MSD Animal Health Details
2.8.2 MSD Animal Health Major Business
2.8.3 MSD Animal Health Live Attenuated Vaccine for Pig Product and Services
2.8.4 MSD Animal Health Live Attenuated Vaccine for Pig Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 MSD Animal Health Recent Developments/Updates
3 Competitive Environment: Live Attenuated Vaccine for Pig by Manufacturer
3.1 Global Live Attenuated Vaccine for Pig Sales Quantity by Manufacturer (2018-2023)
3.2 Global Live Attenuated Vaccine for Pig Revenue by Manufacturer (2018-2023)
3.3 Global Live Attenuated Vaccine for Pig Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Live Attenuated Vaccine for Pig by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Live Attenuated Vaccine for Pig Manufacturer Market Share in 2022
3.4.2 Top 6 Live Attenuated Vaccine for Pig Manufacturer Market Share in 2022
3.5 Live Attenuated Vaccine for Pig Market: Overall Company Footprint Analysis
3.5.1 Live Attenuated Vaccine for Pig Market: Region Footprint
3.5.2 Live Attenuated Vaccine for Pig Market: Company Product Type Footprint
3.5.3 Live Attenuated Vaccine for Pig Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Live Attenuated Vaccine for Pig Market Size by Region
4.1.1 Global Live Attenuated Vaccine for Pig Sales Quantity by Region (2018-2029)
4.1.2 Global Live Attenuated Vaccine for Pig Consumption Value by Region (2018-2029)
4.1.3 Global Live Attenuated Vaccine for Pig Average Price by Region (2018-2029)
4.2 North America Live Attenuated Vaccine for Pig Consumption Value (2018-2029)
4.3 Europe Live Attenuated Vaccine for Pig Consumption Value (2018-2029)
4.4 Asia-Pacific Live Attenuated Vaccine for Pig Consumption Value (2018-2029)
4.5 South America Live Attenuated Vaccine for Pig Consumption Value (2018-2029)
4.6 Middle East and Africa Live Attenuated Vaccine for Pig Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2029)
5.2 Global Live Attenuated Vaccine for Pig Consumption Value by Type (2018-2029)
5.3 Global Live Attenuated Vaccine for Pig Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2029)
6.2 Global Live Attenuated Vaccine for Pig Consumption Value by Application (2018-2029)
6.3 Global Live Attenuated Vaccine for Pig Average Price by Application (2018-2029)
7 North America
7.1 North America Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2029)
7.2 North America Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2029)
7.3 North America Live Attenuated Vaccine for Pig Market Size by Country
7.3.1 North America Live Attenuated Vaccine for Pig Sales Quantity by Country (2018-2029)
7.3.2 North America Live Attenuated Vaccine for Pig Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2029)
8.2 Europe Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2029)
8.3 Europe Live Attenuated Vaccine for Pig Market Size by Country
8.3.1 Europe Live Attenuated Vaccine for Pig Sales Quantity by Country (2018-2029)
8.3.2 Europe Live Attenuated Vaccine for Pig Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Live Attenuated Vaccine for Pig Market Size by Region
9.3.1 Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Live Attenuated Vaccine for Pig Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2029)
10.2 South America Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2029)
10.3 South America Live Attenuated Vaccine for Pig Market Size by Country
10.3.1 South America Live Attenuated Vaccine for Pig Sales Quantity by Country (2018-2029)
10.3.2 South America Live Attenuated Vaccine for Pig Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Live Attenuated Vaccine for Pig Market Size by Country
11.3.1 Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Live Attenuated Vaccine for Pig Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Live Attenuated Vaccine for Pig Market Drivers
12.2 Live Attenuated Vaccine for Pig Market Restraints
12.3 Live Attenuated Vaccine for Pig Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Live Attenuated Vaccine for Pig and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live Attenuated Vaccine for Pig
13.3 Live Attenuated Vaccine for Pig Production Process
13.4 Live Attenuated Vaccine for Pig Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Live Attenuated Vaccine for Pig Typical Distributors
14.3 Live Attenuated Vaccine for Pig Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Live Attenuated Vaccine for Pig Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Live Attenuated Vaccine for Pig Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Live Attenuated Vaccine for Pig Product and Services
Table 6. Merck Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Live Attenuated Vaccine for Pig Product and Services
Table 11. Pfizer Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Live Attenuated Vaccine for Pig Product and Services
Table 16. GlaxoSmithKline Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Astellas Pharma Major Business
Table 20. Astellas Pharma Live Attenuated Vaccine for Pig Product and Services
Table 21. Astellas Pharma Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Astellas Pharma Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Live Attenuated Vaccine for Pig Product and Services
Table 26. Johnson & Johnson Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. CSL Basic Information, Manufacturing Base and Competitors
Table 29. CSL Major Business
Table 30. CSL Live Attenuated Vaccine for Pig Product and Services
Table 31. CSL Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. CSL Recent Developments/Updates
Table 33. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 34. KM Biologics Major Business
Table 35. KM Biologics Live Attenuated Vaccine for Pig Product and Services
Table 36. KM Biologics Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. KM Biologics Recent Developments/Updates
Table 38. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 39. MSD Animal Health Major Business
Table 40. MSD Animal Health Live Attenuated Vaccine for Pig Product and Services
Table 41. MSD Animal Health Live Attenuated Vaccine for Pig Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. MSD Animal Health Recent Developments/Updates
Table 43. Global Live Attenuated Vaccine for Pig Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 44. Global Live Attenuated Vaccine for Pig Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Live Attenuated Vaccine for Pig Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Live Attenuated Vaccine for Pig, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Live Attenuated Vaccine for Pig Production Site of Key Manufacturer
Table 48. Live Attenuated Vaccine for Pig Market: Company Product Type Footprint
Table 49. Live Attenuated Vaccine for Pig Market: Company Product Application Footprint
Table 50. Live Attenuated Vaccine for Pig New Market Entrants and Barriers to Market Entry
Table 51. Live Attenuated Vaccine for Pig Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Live Attenuated Vaccine for Pig Sales Quantity by Region (2018-2023) & (Units)
Table 53. Global Live Attenuated Vaccine for Pig Sales Quantity by Region (2024-2029) & (Units)
Table 54. Global Live Attenuated Vaccine for Pig Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Live Attenuated Vaccine for Pig Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Live Attenuated Vaccine for Pig Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Live Attenuated Vaccine for Pig Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2023) & (Units)
Table 59. Global Live Attenuated Vaccine for Pig Sales Quantity by Type (2024-2029) & (Units)
Table 60. Global Live Attenuated Vaccine for Pig Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Live Attenuated Vaccine for Pig Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Live Attenuated Vaccine for Pig Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Live Attenuated Vaccine for Pig Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2023) & (Units)
Table 65. Global Live Attenuated Vaccine for Pig Sales Quantity by Application (2024-2029) & (Units)
Table 66. Global Live Attenuated Vaccine for Pig Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Live Attenuated Vaccine for Pig Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Live Attenuated Vaccine for Pig Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Live Attenuated Vaccine for Pig Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2023) & (Units)
Table 71. North America Live Attenuated Vaccine for Pig Sales Quantity by Type (2024-2029) & (Units)
Table 72. North America Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2023) & (Units)
Table 73. North America Live Attenuated Vaccine for Pig Sales Quantity by Application (2024-2029) & (Units)
Table 74. North America Live Attenuated Vaccine for Pig Sales Quantity by Country (2018-2023) & (Units)
Table 75. North America Live Attenuated Vaccine for Pig Sales Quantity by Country (2024-2029) & (Units)
Table 76. North America Live Attenuated Vaccine for Pig Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Live Attenuated Vaccine for Pig Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2023) & (Units)
Table 79. Europe Live Attenuated Vaccine for Pig Sales Quantity by Type (2024-2029) & (Units)
Table 80. Europe Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2023) & (Units)
Table 81. Europe Live Attenuated Vaccine for Pig Sales Quantity by Application (2024-2029) & (Units)
Table 82. Europe Live Attenuated Vaccine for Pig Sales Quantity by Country (2018-2023) & (Units)
Table 83. Europe Live Attenuated Vaccine for Pig Sales Quantity by Country (2024-2029) & (Units)
Table 84. Europe Live Attenuated Vaccine for Pig Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Live Attenuated Vaccine for Pig Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2023) & (Units)
Table 87. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Type (2024-2029) & (Units)
Table 88. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2023) & (Units)
Table 89. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Application (2024-2029) & (Units)
Table 90. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Region (2018-2023) & (Units)
Table 91. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity by Region (2024-2029) & (Units)
Table 92. Asia-Pacific Live Attenuated Vaccine for Pig Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Live Attenuated Vaccine for Pig Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2023) & (Units)
Table 95. South America Live Attenuated Vaccine for Pig Sales Quantity by Type (2024-2029) & (Units)
Table 96. South America Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2023) & (Units)
Table 97. South America Live Attenuated Vaccine for Pig Sales Quantity by Application (2024-2029) & (Units)
Table 98. South America Live Attenuated Vaccine for Pig Sales Quantity by Country (2018-2023) & (Units)
Table 99. South America Live Attenuated Vaccine for Pig Sales Quantity by Country (2024-2029) & (Units)
Table 100. South America Live Attenuated Vaccine for Pig Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Live Attenuated Vaccine for Pig Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Type (2018-2023) & (Units)
Table 103. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Type (2024-2029) & (Units)
Table 104. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Application (2018-2023) & (Units)
Table 105. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Application (2024-2029) & (Units)
Table 106. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Region (2018-2023) & (Units)
Table 107. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity by Region (2024-2029) & (Units)
Table 108. Middle East & Africa Live Attenuated Vaccine for Pig Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Live Attenuated Vaccine for Pig Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Live Attenuated Vaccine for Pig Raw Material
Table 111. Key Manufacturers of Live Attenuated Vaccine for Pig Raw Materials
Table 112. Live Attenuated Vaccine for Pig Typical Distributors
Table 113. Live Attenuated Vaccine for Pig Typical Customers
List of Figures
Figure 1. Live Attenuated Vaccine for Pig Picture
Figure 2. Global Live Attenuated Vaccine for Pig Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Live Attenuated Vaccine for Pig Consumption Value Market Share by Type in 2022
Figure 4. Bacterial Vaccines Examples
Figure 5. Viral Vaccines Examples
Figure 6. Global Live Attenuated Vaccine for Pig Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Live Attenuated Vaccine for Pig Consumption Value Market Share by Application in 2022
Figure 8. Piglet Examples
Figure 9. Adult Pig Examples
Figure 10. Global Live Attenuated Vaccine for Pig Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Live Attenuated Vaccine for Pig Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Live Attenuated Vaccine for Pig Sales Quantity (2018-2029) & (Units)
Figure 13. Global Live Attenuated Vaccine for Pig Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Live Attenuated Vaccine for Pig Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Live Attenuated Vaccine for Pig Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Live Attenuated Vaccine for Pig by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Live Attenuated Vaccine for Pig Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Live Attenuated Vaccine for Pig Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Live Attenuated Vaccine for Pig Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Live Attenuated Vaccine for Pig Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Live Attenuated Vaccine for Pig Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Live Attenuated Vaccine for Pig Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Live Attenuated Vaccine for Pig Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Live Attenuated Vaccine for Pig Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Live Attenuated Vaccine for Pig Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Live Attenuated Vaccine for Pig Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Live Attenuated Vaccine for Pig Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Live Attenuated Vaccine for Pig Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Live Attenuated Vaccine for Pig Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Live Attenuated Vaccine for Pig Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Live Attenuated Vaccine for Pig Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Live Attenuated Vaccine for Pig Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Live Attenuated Vaccine for Pig Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Live Attenuated Vaccine for Pig Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Live Attenuated Vaccine for Pig Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Live Attenuated Vaccine for Pig Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Live Attenuated Vaccine for Pig Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Live Attenuated Vaccine for Pig Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Live Attenuated Vaccine for Pig Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Live Attenuated Vaccine for Pig Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Live Attenuated Vaccine for Pig Consumption Value Market Share by Region (2018-2029)
Figure 52. China Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Live Attenuated Vaccine for Pig Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Live Attenuated Vaccine for Pig Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Live Attenuated Vaccine for Pig Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Live Attenuated Vaccine for Pig Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Live Attenuated Vaccine for Pig Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Live Attenuated Vaccine for Pig Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Live Attenuated Vaccine for Pig Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Live Attenuated Vaccine for Pig Market Drivers
Figure 73. Live Attenuated Vaccine for Pig Market Restraints
Figure 74. Live Attenuated Vaccine for Pig Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Live Attenuated Vaccine for Pig in 2022
Figure 77. Manufacturing Process Analysis of Live Attenuated Vaccine for Pig
Figure 78. Live Attenuated Vaccine for Pig Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


★調査レポート[世界の豚用弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23SM7912)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の豚用弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の豚熱生ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経口狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のmRNA新型コロナウイルスワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のHPV四価ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経口コレラワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のJE不活化ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の新型コロナウイルス感染用症経口ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の牛疫ウイルスワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経鼻ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の豚連鎖球菌ワクチン市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆